CGAS rs200818241: What Your Genotype Means
The rs200818241 variant is an exceptionally rare missense mutation located within the CGAS gene. It has gained scientific interest due to its identification in multigenerational long-lived families, where it appears to moderately dampen innate immune signaling. Research associates this variant with reduced age-related chronic inflammation and delayed cellular senescence, though the overall epidemiological evidence remains limited.
What each genotype means
Typical cGAS signaling
This is the common, wild-type genotype for the CGAS gene. It represents the standard baseline for cGAS-STING pathway activity, which is a normal part of the body's immune response to cellular stress and DNA damage.
This is the most common genotype found in the general population.
Reduced cGAS protein stability
This genotype includes one copy of the rare variant associated with longevity in some families. Research indicates this variant may reduce cGAS protein stability and dampen cGAS-STING signaling, which could potentially mitigate chronic inflammation and delay cellular senescence.
This genotype is very rare, with the variant allele occurring at a frequency of less than 0.1% in global populations.
Significantly reduced cGAS signaling
This genotype carries two copies of the rare variant. While studies have shown this variant can attenuate cGAS-STING pathway activation in cell models, the clinical implications of having two copies are not fully established in large-scale human populations.
This genotype is extremely rare and is not commonly observed in standard population databases.
Genetic Architecture and Variant Location
The single nucleotide polymorphism (SNP) designated rs200818241 represents a rare coding alteration located within the CGAS gene. As a missense mutation, this change alters a single amino acid in the encoded protein sequence of cyclic GMP-AMP synthase. In normal cellular physiology, this region is structurally critical for proper protein folding and durability. Laboratory characterizations indicate that the altered amino acid reduces the physical stability of the cGAS enzyme, accelerating its degradation relative to the standard wild-type protein. Because of this decreased molecular stability, cells carrying the variant maintain lower basal levels of the enzyme across certain tissues. Rather than completely abolishing protein function, this mutation acts as a calibrated, hypomorphic change that preserves essential defense mechanisms while selectively reducing chronic, excessive signal output.
The Biological Role of CGAS and the STING Pathway
The CGAS gene encodes cyclic GMP-AMP synthase, a critical cytoplasmic sensor belonging to the innate immune system. Under healthy conditions, nuclear and mitochondrial DNA are strictly sequestered within cellular compartments. However, during cellular stress, viral infection, or progressive aging, fragments of DNA can leak aberrantly into the cytoplasm. cGAS directly binds to this mislocalized double-stranded DNA, synthesizing the secondary messenger cGAMP. This molecule then binds and activates the STING (stimulator of interferon genes) adaptor protein, triggering a cascade that upregulates type I interferons and pro-inflammatory cytokines like interleukin-6 and CXCL8. While essential for clearing pathogens, persistent, low-grade cGAS-STING activation across decades fuels 'inflammaging,' a chronic sterile inflammatory state that accelerates tissue decay and hastens cellular senescence.
Current Research and Longevity Associations
Scientific evidence connecting rs200818241 to extended healthspan largely emerged from whole-genome linkage analyses conducted in cohorts such as the Leiden Longevity Study. Investigators studying long-lived nonagenarian siblings observed this rare variant enriched in select multigenerational families displaying exceptional survival. In human mesenchymal stromal cells and astrocytes, the variant substantially blunted downstream STING target activation and delayed senescence markers, such as p16 expression, without entirely disabling antimicrobial defenses. However, evidence strength is currently classified as limited. The variant was identified in only a tiny fraction of long-lived families, and genome-wide association studies across broad unselected populations have not yet confirmed a wide-scale longevity effect. Further validation in diverse cohorts is necessary to define its exact epidemiological impact.
Population Distribution and Global Frequency
According to broad population reference resources such as the Genome Aggregation Database (gnomAD), rs200818241 is an exceptionally rare genetic event. Its global minor allele frequency (MAF) falls well below 0.1% (MAF < 0.001) across diverse continental ancestries, with the vast majority of cataloged carriers appearing in cohorts of European descent. In everyday terms, more than 99.9% of people worldwide possess two copies of the ancestral wild-type reference allele. Because it is absent or nearly absent across most non-European groups, the variant represents an ultra-rare familial lineage marker rather than a common driver of population-level lifespan differences. Standard commercial genotyping microarrays rarely capture this variant directly, usually requiring high-depth whole-genome or exome sequencing for reliable detection.
Clinical Interpretation and Practical Implications
Carrying or lacking the rs200818241 variant cannot be used to diagnose any medical condition, nor can it predict an individual's personal lifespan. Exceptional longevity and overall healthspan are polygenic traits influenced by thousands of subtle genetic markers interacting dynamically with environmental variables, physical activity, diet, and stress management. Discovering that you do not carry this mutation is entirely normal and does not imply an elevated risk for premature aging. Furthermore, individuals carrying the rare allele are not immune to chronic disease. The primary value of rs200818241 lies in basic research, where it highlights the cGAS-STING inflammatory pathway as a prime biological target for pharmacological therapies aimed at combating age-related degenerative conditions.
How common is this variant?
The rs200818241 variant is an ultra-rare allele in gnomAD across all global populations, displaying a minor allele frequency of less than 0.001 (0.1%). Over 99.9% of the world's population carries the standard homozygous wild-type genotype.
Frequently asked questions
Does having the rs200818241 variant guarantee a long life?
No, carrying this variant does not guarantee extreme longevity. While it has been identified in families with remarkable healthspans, human aging is dictated by a complex combination of hundreds of genetic variants alongside diet, lifestyle, and environment. A single rare variant provides only a subtle biological modulation rather than an absolute health outcome.
Can standard commercial DNA kits detect rs200818241?
Most standard consumer direct-to-consumer genotyping microarrays do not include rs200818241 because it is an ultra-rare coding variant. Identifying this variant typically requires targeted clinical Sanger sequencing, whole-exome sequencing, or high-coverage whole-genome sequencing. Check your raw data file annotations to confirm if this specific position was assayed.
Does this mutation weaken the immune system against viruses?
Experimental models suggest that rs200818241 dampens inflammatory overactivation rather than completely eliminating the cGAS-STING pathway. Because the reduction in activity is calibrated and cell-type specific, carrier cells still maintain baseline immune responses to external biological threats. There is currently no evidence showing that carriers suffer from clinical immune deficiencies.
Can I mimic the effects of this variant through lifestyle?
Because the variant acts by mitigating chronic sterile inflammation, lifestyle practices known to counter systemic inflammation can support similar biological pathways. Maintaining regular moderate cardiovascular exercise, consuming a balanced anti-inflammatory diet, and getting restorative sleep all help control the chronic low-grade inflammation that naturally accelerates biological aging.
Sources & further reading
Educational information only, last refreshed 9/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs200818241?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29